Morgan Stanley’s Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares DNAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28
Closed -$286 7747
2023
Q1
$286 Hold
28
﹤0.01% 7490
2022
Q4
$282 Hold
28
﹤0.01% 7612
2022
Q3
$0 Sell
28
-3,100
-99% -$30.3K ﹤0.01% 8023
2022
Q2
$30K Sell
3,128
-3,408
-52% -$33.1K ﹤0.01% 6843
2022
Q1
$64K Sell
6,536
-1,539
-19% -$14.9K ﹤0.01% 6582
2021
Q4
$80K Buy
8,075
+2,600
+47% +$25.7K ﹤0.01% 6570
2021
Q3
$54K Buy
+5,475
New +$53.9K ﹤0.01% 6687

Other funds holding DNAB

Morgan Stanley's DNAB Position: Q2 2023 in Review

Morgan Stanley sold out of Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares (DNAB) in Q2 2023, closing a stake of 28 shares — an estimated $286 sold.

Morgan Stanley first reported a position in DNAB in Q3 2021 and held it in 7 quarters. The position peaked at $80K in Q4 2021. 49 funds tracked by Wall St. Rank hold DNAB as of Q2 2023.

  • Morgan Stanley reported no remaining Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Morgan Stanley sold 28 Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares shares in Q2 2023, an estimated $286.
  • Morgan Stanley first reported a position in Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares in Q3 2021 and held it in 7 quarters.
  • Morgan Stanley's Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares position peaked at $80K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.